Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 5 | — | IM / LA |
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 3 | — | IM / RA |
Fever, marked confusion, inability to walk Hydration in hospital; released in stable condition after one overnight in the hospital
CLL
CLL
Dexilant 60 mg; Tamsulosin 0.4 mg; AREDS 2
Amoxicillin; Vancomycin
September 16, 2025:MRI OF HEAD-No acute findings; CT of Head and Neck - no acute findings; Respiratory Panel - nothing detected; TnT-Gen5-23; Delta -8; Lactic Acid 0.9; P±T 15; IN±R INR 1.1; Glucose 117; Blood Culture - no growth; Procalcitonin .16; CK 583; CKMB 2.52; AMMONIA 14; NT-ProBNP 843; Urinalysis - normal ecept small blood, protein 30; ketones 15; WBC's 3-5; Ethanol <10; Magnesium 2; Chest -ray - no acute process; CBC wbc 8.6; RBC 5.1; HGB 14.7; HCT 44.8; MCV 87.8; MCH 28.8; MCHC 32.8; PLT 124; RDW 41.1; MPV 10.5; ABSOLUTE NEUTROPHIL COUNT 6.24; ABSOLUTE LYMPHOCYTE COUNT 1.77; CMP -normal except na-134; glucose 138; creatinine 1.32, AST 58; TSH .74; HEMOGLOBIN A1C 5.5; ECG - NORMAL
MODERNA COVID-19; Weakness and ataxia; age 80; 09/15/2024